The hippocampus in aging and Alzheimer's disease.

TitleThe hippocampus in aging and Alzheimer's disease.
Publication TypeJournal Article
Year of Publication1995
Authorsde Leon MJ, Convit A, DeSanti S, Golomb J, Tarshish C, Rusinek H, Bobinski M, Ince C, Miller DC, Wisniewski HM
JournalNeuroimaging Clin N Am
Volume5
Issue1
Pagination1-17
Date Published1995 Feb
ISSN1052-5149
KeywordsAged, Aged, 80 and over, Aging, Alzheimer Disease, Atrophy, Dementia, Diagnosis, Differential, Diagnostic Imaging, Hippocampus, Humans, Parkinson Disease, Putamen
Abstract

The role of imaging in the evaluation of neurodegenerative disorders is summarized. The primary role of imaging is to exclude potentially treatable disorders such as meningioma, extracerebral hematoma, Wernicke's disease, and hypothyroidism. Atrophic changes dominate in the hippocampal region on Alzheimer's disease versus the anterior, frontal, and temporal lobes in Pick's disease. Signal hypointensity in the putamen on T2-weighted spin-echo images favors poorly drug-responsive Parkinson's disease whereas putaminal hyperintensity is observed with Creutzfeldt-Jacob, Wilson's, and Leigh's diseases. As our population ages, a thorough understanding of imaging findings in a geriatric population assumes an increasing importance.

Alternate JournalNeuroimaging Clin N Am
PubMed ID7743078
Grant ListP01 AG04220 / AG / NIA NIH HHS / United States
P30 AG08051 / AG / NIA NIH HHS / United States
R01 AG12101 / AG / NIA NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065